CBU
ERAS icon

CIBC Bancorp USA’s Erasca ERAS Stock Holding History

CIBC Bancorp USA’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$40.3K Buy
+18,504
New +$29.4K ﹤0.01% 1432

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CIBC Bancorp USA's ERAS Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Erasca (ERAS) in Q3 2025: 18,504 shares worth $40.3K. The stake represents ﹤0.01% of the portfolio and ranks #1432 among its holdings.

141 funds tracked by Wall St. Rank hold ERAS as of Q3 2025.

  • CIBC Bancorp USA held 18,504 shares of Erasca worth $40.3K as of Q3 2025.
  • Erasca was a new CIBC Bancorp USA position in Q3 2025.
  • Erasca made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1432 holding.
  • 141 funds tracked by Wall St. Rank held Erasca as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.